Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 175

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas

Open access
Tichomirowa, Maria A, Barlier, Anne, Daly, Adrian F, Jaffrain-Rea, Marie-Lise, Ronchi, Cristina, Yaneva, Maria, Urban, Jonathan D, Petrossians, Patrick, Elenkova, Atanaska, Tabarin, Antoine, Desailloud, Rachel, Maiter, Dominique, Schürmeyer, Thomas, Cozzi, Renato, Theodoropoulou, Marily, Sievers, Caroline, Bernabeu, Ignacio, Naves, Luciana A, Chabre, Olivier, Fajardo Montañana, Carmen, Hana, Vaclav, Halaby, Georges, Delemer, Brigitte, Labarta Aizpún, José Ignacio, Sonnet, Emmanuel, Ferrandez Longás, Ángel, Hagelstein, Marie-Thérèse, Caron, Philippe, Stalla, Günter K, Bours, Vincent, Zacharieva, Sabina, Spada, Anna, Brue, Thierry, Beckers, Albert·2011·European Journal of Endocrinology

Abstract

Background: Aryl hydrocarbon receptor interacting protein (AIP) mutations (AIPmut) cause aggressive pituitary adenomas in young patients, usually in the setting of familial isolated pituitary adenomas. The prevalence of AIPmut among sporadic pituitary adenoma patients appears to be low; studies have not addressed prevalence in the most clinically relevant population. Hence, we undertook an international, multicenter, prospective genetic, and clinical analysis at 21 tertiary referral endocrine departments. Methods: We included 163 sporadic pituitary macroadenoma patients irrespective of clinical phenotype diagnosed at <30 years of age. Results: Overall, 19/163 (11.7%) patients had germline AIPmut; a further nine patients had sequence changes of uncertain significance or polymorphisms.AIPmut were identified in 8/39 (20.5%) pediatric patients. Ten AIPmut were identified in 11/83 (13.3%) sporadic somatotropinoma patients, in 7/61 (11.5%) prolactinoma patients, and in 1/16 non-functioning pituitary adenoma patients. Large genetic deletions were not seen using multiplex ligation-dependent probe amplification. Familial screening was possible in the relatives of seven patients with AIP mut and carriers were found in six of the seven families. In total, pituitary adenomas were diagnosed in 2/21 AIPmut-screened carriers; both had asymptomatic microadenomas. Conclusion: Germline AIPmut occur in 11.7% of patients <30 years with sporadic pituitary macroadenomas and in 20.5% of pediatric patients.AIPmut mutation testing in this population should be considered in order to optimize clinical genetic investigation and management.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1530/eje-11-0304

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 175

Metadata

Authors
Tichomirowa, M. A., Barlier, A., Daly, A. F., Jaffrain-Rea, M.-L., Ronchi, C., Yaneva, M., Urban, J. D., Petrossians, P., Elenkova, A., Tabarin, A., Desailloud, R., Maiter, D., Schürmeyer, T., Cozzi, R., Theodoropoulou, M., Sievers, C., Bernabeu, I., Naves, L. A., Chabre, O., Fajardo Montañana, C., Hana, V., Halaby, G., Delemer, B., Labarta Aizpún, J. I., Sonnet, E., Ferrandez Longás, Á., Hagelstein, M.-T., Caron, P., Stalla, G. K., Bours, V., Zacharieva, S., Spada, A., Brue, T., & Beckers, A.
Venue
European Journal of Endocrinology
Published
2011-10
Volume
165
Issue
4
Pages
509-515
ISSN
  • 0804-4643 (ISSN-L)
  • 1479-683X
OpenAlex
W2123383145
Cited by
175
References
1
FWCI
12.47
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas. https://app.cochat.ai/papers/10.1530/eje-11-0304
The paper
Tichomirowa, M. A., Barlier, A., Daly, A. F., Jaffrain-Rea, M.-L., Ronchi, C., Yaneva, M., Urban, J. D., Petrossians, P., Elenkova, A., Tabarin, A., Desailloud, R., Maiter, D., Schürmeyer, T., Cozzi, R., Theodoropoulou, M., Sievers, C., Bernabeu, I., Naves, L. A., Chabre, O., . . . Beckers, A. (2011). High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas. European Journal of Endocrinology. https://doi.org/10.1530/eje-11-0304

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.